+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dietary Supplements Market Size, Share & Trends Analysis Report by Ingredient (Vitamins, Minerals), by Form, by Application, by End User, by Distribution Channel, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4479727
  • Report
  • February 2020
  • Region: Global
  • 135 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Archer Daniels Midland
  • Bionova Lifesciences
  • Ekomir
  • Herbalife International
  • Nutraceutics Corporation
  • MORE
The global dietary supplements market size is projected to reach USD 230.73 billion by 2027, registering a CAGR of 8.2% over the forecast period. The market is backed by rising health awareness globally among consumers of all age groups coupled with a considerable rise in the number of fitness centers and gymnasiums.

The dietary supplements industry is driven by the hectic work schedules among working individuals coupled with fluctuations in diet intervals. Such factors have promoted the sale of dietary and nutritional supplements in the form of powder, liquids, and capsules across the globe. Rising importance of microencapsulation in the pharmaceutical industry to ensure color characteristics and the quality of finished ingredients is likely to force dietary supplements manufacturers to use capsule dosage forms over the forecast period.

Growing awareness towards calorie reduction and weight loss in major markets including the U.S., China, and Italy is expected to promote the application of health and wellness segment and thus, in turn, will have a substantial impact on the industry. Furthermore, increasing importance of protein intake in emerging markets of China and India on account of implementation of new advertising campaigns for brand promotions by companies including Amway and Pfizer is expected to remain a driving force over the forecast period.

Dietary supplement ingredients including vitamin, mineral blends, carotenoids, and omega-3 are also used for reducing the risk of malnutrition in adults and infants. High birth rate, rising geriatric population, and increased number of premature births and a surge in the number of patients getting treated for malnutrition is expected to promote the usage of clinical nutrition products over the forecast period.

North America emerged as the largest market for dietary supplements in 2019. On a macro level, rising awareness pertaining to nutritional enrichment in the region is expected to propel the demand for the product in the coming years. Moreover, rising demand of sports as an academic curriculum activity in education systems in major markets including the U.S., Russia, China and Japan is expected to promote the application of dietary supplements among children over the coming years.

Energy and weight management is expected to remain dominant throughout the forecast period owing to the rising awareness towards fat reduction and increasing focus on enhancing nutrition intake among adults.

Further key findings from the report suggest:
  • In terms of revenue, proteins and amino acids segment is projected to ascend at a CAGR of 12.8% over the forecast period
  • Soft gels and capsules segment contributed approximately over 34.8% to the total market in 2019
  • Over the counter dietary supplements dominated the global market in 2019, constituting a revenue share of over 73% in 2019
  • In terms of ingredient, vitamins emerged as the largest segment in 2019, registering a revenue of USD 39.61 billion. The segment is expected to grow at a CAGR of 5.8% in the coming years.
  • In terms of product, tablets accounted for the largest share in 2019 and registered a revenue of USD 43.06 billion. The growth of the segment is attributable to the increasing popularity of tablets owing to their easy dosage patterns.
  • Asia Pacific is expected to witness the fastest growth over the forecast period. Expansion of the retail chain in countries such as India, Japan, and China has increased the rate of dietary supplements consumption in this region.
  • The dietary supplements market represents a highly competitive landscape. Key market players dominate the market space and have been focusing on various strategic initiatives including mergers & acquisitions, product innovation, and portfolio expansion.
  • The key market participants include Amway, Arkopharma Laboratoires Pharmaceutiques, Abbott Laboratories, Archer Daniels Midland, Bayer, and Glanbia, among others

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Archer Daniels Midland
  • Bionova Lifesciences
  • Ekomir
  • Herbalife International
  • Nutraceutics Corporation
  • MORE
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased Database
1.1.2. Internal Database
1.1.3. Secondary Sources & Third-Party Perspectives
1.1.4. Primary Research
1.2. Information Analysis
1.2.1. Data Analysis Models
1.3. Market Formulation & Data Visualization
1.4. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights

Chapter 3. Dietary Supplements Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Raw Material Trends
3.3.1.1. Major Raw Material Trends
3.3.1.2. Procurement Best Practices
3.3.2. Manufacturing trends
3.3.2.1. Technology Trends
3.3.2.2. Outsourcing and contract manufacturing trends
3.3.3. Sales Channel Analysis
3.4. Regulatory Framework
3.5. Dietary Supplements Market - Market dynamics
3.5.1. Market driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Industry Challenges
3.6. Business Environment Analysis: Dietary Supplements Market
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Economic Landscape
3.6.2.6. Legal Landscape
3.6.3. Major Deals & Strategic Alliances Analysis
3.6.3.1. Joint Ventures
3.6.3.2. Mergers & Acquisitions
3.7. Market Entry Strategy

Chapter 4. Dietary Supplements Market: Ingredient Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Dietary Supplements Market: Ingredient Movement Analysis, 2019 & 2027
4.3. Vitamins
4.3.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.4. Botanicals
4.4.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.5. Minerals
4.5.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.6. Protein & Amino Acids
4.6.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.7. Fibers & Specialty Carbohydrates
4.7.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.8. Omega & Fatty Acids
4.8.1. Market estimates and forecasts, 2016 - 2027 (USD Million)
4.9. Others
4.9.1. Market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 5. Dietary Supplements Market: Form Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Dietary Supplements Market: Form Movement Analysis, 2019 & 2027
5.3. Tablet
5.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.4. Capsules
5.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.5. Powder
5.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.6. Liquids
5.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.7. Soft gels
5.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.8. Gummies
5.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
5.9. Others
5.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6. Dietary Supplements Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Dietary Supplements Market: Application Movement Analysis, 2019 & 2027
6.3. Energy & Weight Management
6.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.4. General Health
6.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.5. Bone & Joint Health
6.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.6. Gastrointestinal Health
6.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.7. Immunity
6.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.8. Cardiac Health
6.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.9. Diabetes
6.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.10. Anti-cancer
6.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
6.11. Others
6.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7. Dietary Supplements Market: End User Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Dietary Supplements Market: End User Movement Analysis, 2019 & 2027
7.3. Infants
7.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.4. Children
7.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.5. Adults
7.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.6. Pregnant women
7.6.1. Market estimates and forecast, 2016 - 2027 (USD Million))
7.7. Geriatric
7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8. Dietary Supplements Market: Distribution Channel Estimates & Trend Analysis
8.1. Definitions & Scope
8.2. Dietary Supplements Market: Distribution Channel Movement Analysis, 2019 & 2027
8.3. OTC
8.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.4. Prescribed
8.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 9. Dietary Supplements Market: Regional Estimates & Trend Analysis
9.1. Dietary Supplements Market: Regional Movement Analysis, 2019 & 2027
9.2. North America
9.2.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.2.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.2.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.2.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.2.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.2.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.2.7. U.S.
9.2.7.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.2.7.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.2.7.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.2.7.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.2.7.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.2.7.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.2.8. Canada
9.2.8.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.2.8.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.2.8.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.2.8.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.2.8.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.2.8.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.2.9. Mexico
9.2.9.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.2.9.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.2.9.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.2.9.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.2.9.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.2.9.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3. Europe
9.3.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3.7. U.K.
9.3.7.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.7.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.7.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.7.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.7.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.7.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3.8. Germany
9.3.8.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.8.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.8.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.8.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.8.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.8.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3.9. France
9.3.9.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.9.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.9.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.9.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.9.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.9.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3.10. Italy
9.3.10.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.10.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.10.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.10.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.10.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.10.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.3.11. Spain
9.3.11.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.3.11.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.3.11.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.3.11.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.3.11.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.3.11.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.4. Asia Pacific
9.4.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.4.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.4.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.4.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.4.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.4.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.4.7. China
9.4.7.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.4.7.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.4.7.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.4.7.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.4.7.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.4.7.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.4.8. Japan
9.4.8.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.4.8.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.4.8.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.4.8.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.4.8.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.4.8.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.4.9. Australia & New Zealand
9.4.9.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.4.9.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.4.9.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.4.9.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.4.9.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.4.9.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.5. Central & South America
9.5.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.5.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.5.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.5.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.5.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.5.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.5.7. Brazil
9.5.7.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.5.7.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.5.7.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.5.7.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.5.7.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.5.7.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.5.8. Peru
9.5.8.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.5.8.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.5.8.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.5.8.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.5.8.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.5.8.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.5.9. Chile
9.5.9.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.5.9.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.5.9.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.5.9.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.5.9.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.5.9.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.6. Middle East & Africa
9.6.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.6.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.6.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.6.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.6.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.6.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.6.7. Saudi Arabia
9.6.7.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.6.7.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.6.7.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.6.7.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.6.7.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.6.7.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)
9.6.8. South Africa
9.6.8.1. Market Estimates and Forecasts, 2016 - 2027 (USD Million)
9.6.8.2. Market Estimates and Forecasts, by Ingredients, 2016 - 2027 (USD Million)
9.6.8.3. Market Estimates and Forecasts, by Form, 2016 - 2027 (USD Million)
9.6.8.4. Market Estimates and Forecasts, by Application, 2016 - 2027 (USD Million)
9.6.8.5. Market Estimates and Forecasts, by End-User, 2016 - 2027 (USD Million)
9.6.8.6. Market Estimates and Forecasts, by Distribution Channel, 2016 - 2027 (USD Million)

Chapter 10. Dietary Supplements Market: Competitive Analysis
10.1. Key Players’ Recent Developments & Their Impact
10.2. Key Innovators, Market Leader, and Emerging Players
10.3. Vendor Landscape
10.3.1. List of key distributors & channel partners
10.3.2. Key customers
10.4. Public Companies
10.4.1. Company Market Position Analysis, 2019
10.4.2. Company Ranking, 2019
10.4.3. Competitive Dashboard Analysis
10.4.3.1. Market Differentiators
10.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
10.4.4. SWOT Analysis Of Public Companies
10.5. Private Companies
10.5.1. List of key emerging companies/technology disruptors/innovators
10.5.2. Geographical presence
10.5.3. Company market position analysis, 2019

Chapter 11 Company Profiles
11.1 Amway
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 Arkopharma Laboratoires Pharmaceutiques
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.4 Bayer
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.5 Glanbia
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.6 Pfizer
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Archer Daniels Midland
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Carlyle Group, NBTY Inc.
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives
11.9 Nu Skin Enterprises
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.10 GlaxoSmithKline
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.11 Herbalife International
11.11.1 Company Overview
11.11.2 Financial Performance
11.11.3 Product Benchmarking
11.11.4 Strategic Initiatives
11.12 Nature’s Sunshine Forms
11.12.1 Company Overview
11.12.2 Financial Performance
11.12.3 Product Benchmarking
11.13 Bionova Lifesciences
11.13.1 Company Overview
11.13.2 Financial Performance
11.13.3 Product Benchmarking
11.13.4 Strategic Initiatives
11.14 Ayanda Group AS
11.14.1 Company Overview
11.14.2 Financial Performance
11.14.3 Product Benchmarking
11.14.4 Strategic Initiatives
11.15 XanGo LLC
11.15.1 Company Overview
11.15.2 Financial Performance
11.15.3 Product Benchmarking
11.15.4 Strategic Initiatives
11.16 Nutraceutics Corporation
11.16.1 Company Overview
11.16.2 Financial Performance
11.16.3 Product Benchmarking
11.16.4 Strategic Initiatives
11.17 American Health
11.17.1 Company Overview
11.17.2 Financial Performance
11.17.3 Product Benchmarking
11.17.4 Strategic Initiatives
11.18 Ekomir
11.18.1 Company Overview
11.18.2 Financial Performance
11.18.3 Product Benchmarking
11.18.4 Strategic Initiatives
11.19 Stepan
11.19.1 Company Overview
11.19.2 Financial Performance
11.19.3 Product Benchmarking
11.19.4 Strategic Initiatives
11.20 DuPont
11.20.1 Company Overview
11.20.2 Financial Performance
11.20.3 Product Benchmarking
11.20.4 Strategic Initiatives
11.21 Himalaya Global Holdings Ltd
11.21.1 Company Overview
11.21.2 Financial Performance
11.21.3Product Benchmarking
11.21.4 Strategic Initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amway
  • Abbott Laboratories
  • Arkopharma Laboratoires Pharmaceutiques
  • Bayer
  • Glanbia
  • Pfizer
  • Archer Daniels Midland
  • Carlyle Group, NBTY Inc.
  • Nu Skin Enterprises
  • GlaxoSmithKline
  • Herbalife International
  • Nature’s Sunshine Forms
  • Bionova Lifesciences
  • Ayanda Group AS
  • XanGo LLC
  • Nutraceutics Corporation
  • American Health
  • Ekomir
  • Stepan
  • DuPont
  • Himalaya Global Holdings Ltd
Note: Product cover images may vary from those shown
Adroll
adroll